Regulatory risks can have a direct impact on patients by delaying access to new and potentially life-saving treatments. If a new therapy is caught in regulatory red tape, patients might have to rely on existing treatments that may be less effective or have more severe side effects. Additionally, regulatory challenges can limit the availability of innovative treatments in certain regions, creating disparities in cancer care.